Crystal structures of respiratory pathogen neuraminidases

Biochemical and Biophysical Research Communications

Volumn 380, Issue 3, 2009, Pages 467-471

  Hsiao, Yu Shan ^a   Parker, Dane ^b   Ratner, Adam J ^b   Prince, Alice ^b   Tong, Liang ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NONE   (United States)

Author keywords

Crystal structure; Neuraminidase; Pneumonia; Pseudomonas aeruginosa; Streptococcus pneumoniae

Indexed keywords

BACTERIAL ENZYME; NANA ENZYME; NANP ENZYME; SIALIDASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; CATALYTIC DOMAIN; CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; HUMANS; NEURAMINIDASE; PNEUMOCOCCAL INFECTIONS; PROTEIN CONFORMATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

ANIMALIA; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS PNEUMONIAE;

EID: 60549101305     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.01.108     Document Type: Article

References (33)

1. Taylor G. Sialidases: structures, biological significance and therapeutic potential. Curr. Opin. Struct. Biol. 6 (1996) 830-837
2. World Health Organisation (WHO), Pneumococcal conjugate vaccine for childhood immunization - WHO position paper, Weekly Epidemiological Record, WHO, Geneva, 2007, pp. 93-104.
3. Brueggemann A.B., Pai R., Crook D.W., and Beall B. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog. 3 (2007) e168
4. Singleton R.J., Hennessy T.W., Bulkow L.R., Hammitt L.L., Zulz T., Hurlburt D.A., Butler J.C., Rudolph K., and Parkinson A. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297 (2007) 1784-1792
5. Pettigrew M.M., Fennie K.P., York M.P., Daniels J., and Ghaffar F. Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types. Infect. Immun. 74 (2006) 3360-3365
6. Manco S., Hernon F., Yesilkaya H., Paton J.C., Andrew P.W., and Kadioglu A. Pneumococcal neuraminidases A and B both have essential roles during infection of the respiratory tract and sepsis. Infect. Immun. 74 (2006) 4014-4020
7. Kelly R.T., Farmer S., and Greiff D. Neuraminidase activities of clinical isolates of Diplococcus pneumoniae. J. Bacteriol. 94 (1967) 272-273
8. King S.J., Whatmore A.M., and Dowson C.G. NanA, a neuraminidase from Streptococcus Pneumoniae, shows high levels of sequence diversity at least in part through recombination with Streptococcus oralis. J. Bacteriol. 187 (2005) 5376-5386
9. King S.J., Hippe K.R., Gould J.M., Bae D., Peterson S., Cline R.T., Fasching C., Janoff E.N., and Weiser J.N. Phase variable desialylation of host proteins that bind to Streptococcus pneumoniae in vivo and protect the airway. Mol. Microbiol. 54 (2004) 159-171
10. King S.J., Hippe K.R., and Weiser J.N. Deglycosylation of human glycoconjugates by the sequential activities of exoglycosidases expressed by Streptococcus pneumoniae. Mol. Microbiol. 59 (2006) 961-974
11. Orihuela C.J., Gao G., Francis K.P., Yu J., and Tuomanen E.I. Tissue-specific contributions of pneumococcal virulence factors to pathogenesis. J. Infect. Dis. 190 (2004) 1661-1669
12. Tong H.H., Blue L.E., James M.A., and DeMaria T.F. Evaluation of the virulence of a Streptococcus pneumoniae neuraminidase-deficient mutant in nasopharyngeal colonization and development of otitis media in the chinchilla model. Infect. Immun. 68 (2000) 921-924
13. Sadikot R.T., Blackwell T.S., Christman J.W., and Prince A.S. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am. J. Respir. Crit. Care Med. 171 (2005) 1209-1223
14. Lanotte P., Watt S., Mereghetti L., Dartiguelongue N., Rastegar-Lari A., Goudeau A., and Quentin R. Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins. J. Med. Microbiol. 53 (2004) 73-81
15. Soong G., Muir A., Gomez M.I., Waks J., Reddy B., Planet P., Singh P.K., Kaneko Y., Wolfgang M.C., Hsiao Y.S., Tong L., and Prince A. Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J. Clin. Invest. 116 (2006) 2297-2305
16. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
17. Weeks C.M., and Miller R. The design implementation of SnB v2.0. J. Appl. Crystallogr. 32 (1999) 120-124
18. Terwilliger T.C. SOLVE and RESOLVE: automated structure solution and density modification. Methods Enzymol. 374 (2003) 22-37
19. Jones T.A., Zou J.Y., Cowan S.W., and Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47 Pt. 2 (1991) 110-119
20. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., Read R.J., Rice L.M., Simonson T., and Warren G.L. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54 (1998) 905-921
21. Crennell S.J., Garman E.F., Philippon C., Vasella A., Laver W.G., Vimr E.R., and Taylor G.L. The structures of Salmonella typhimurium LT2 neuraminidase and its complexes with three inhibitors at high resolution. J. Mol. Biol. 259 (1996) 264-280
22. Crennell S., Garman E., Laver G., Vimr E., and Taylor G. Crystal structure of Vibrio cholerae neuraminidase reveals dual lectin-like domains in addition to the catalytic domain. Structure 2 (1994) 535-544
23. Newstead S.L., Potter J.A., Wilson J.C., Xu G., Chien C.H., Watts A.G., Withers S.G., and Taylor G.L. The structure of Clostridium perfringens NanI sialidase and its catalytic intermediates. J. Biol. Chem. 283 (2008) 9080-9088
24. Gaskell A., Crennell S., and Taylor G. The three domains of a bacterial sialidase: a beta-propeller, an immunoglobulin module and a galactose-binding jelly-roll. Structure 3 (1995) 1197-1205
25. Xu G., Li X., Andrew P.W., and Taylor G.L. Structure of the catalytic domain of Streptococcus pneumoniae sialidase NanA. Acta Crystallogr. F64 (2008) 772-775
26. Gut H., King S.J., and Walsh M.A. Structural and functional studies of Streptococcus pneumoniae neuraminidase B: an intramolecular trans-sialidase. FEBS Lett. (2008)
27. Krissinel E., and Henrick K. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr. D60 (2004) 2256-2268
28. Fong S., Hamill S.J., Proctoer M., Freund S.M.V., Benian G.M., Chothia C., Bycroft M., and Clarke J. Structure and stability of an immunoglobulin superfamily domain from twitchin, a muscle protein of the nematode Caenorhabditis elegans. J. Mol. Biol. 264 (1996) 624-639
29. Carr J., Ives J., Kelly L., Lambkin R., Oxford J., Mendel D., Tai L., and Roberts N. Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo. Antiviral Res. 54 (2002) 79-88
30. Amaya M.F., Buschiazzo A., Nguyen T., and Alzari P.M. The high resolution structures of free and inhibitor-bound Trypanosoma rangeli sialidase and its comparison with T. cruzi trans-sialidase. J. Mol. Biol. 325 (2003) 773-784
31. Roggentin P., Schauer R., Hoyer L.L., and Vimr E.R. The sialidase superfamily and its spread by horizontal gene transfer. Mol. Microbiol. 9 (1993) 915-921
32. DeLano W.L. The PyMOL Molecular Graphics System (2002), DeLano Scientific, San Carlos, CA
33. Nicholls A., Sharp K.A., and Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11 (1991) 281-296